Literature DB >> 16178890

Loss of phenotypic expression is related to tumour progression in early gastric differentiated adenocarcinoma.

T Nakamura1, T Yao, A Kabashima, K Nishiyama, Y Maehara, M Tsuneyoshi.   

Abstract

AIMS: To evaluate the relationship between phenotypic expression and tumour progression as represented by macroscopic features, submucosal invasion and lymph node metastasis in early differentiated gastric adenocarcinoma.
METHODS: One hundred and fifty-five cases of early gastric differentiated adenocarcinoma without any poorly differentiated components were studied. The mucosal and submucosal components of carcinomas and lymph node metastatic lesions were classified into four categories, gastric type (G-type), incomplete intestinal type (I-type), complete intestinal type (C-type) and unclassified type (U-type), based on the combination of the phenotypic expression of HGM (gastric foveolar epithelium), MUC 6 (gastric pyloric glands), MUC 2 (intestinal goblet cells) and CD 10 (small intestinal brush border). In addition, a new classification representing a phenotypic shift from mucosa to submucosa or from primary lesion to lymph node metastasis was established with the categories of preserved group (P-group), loss group (L-group) and acquired group (A-group).
RESULTS: (1) In submucosal carcinoma, U-type was more common in the submucosa (39%) than in the mucosa (9%). (2) U-type was more common in the metastatic lesions (42%) than in the primary lesions (5%). (3) The submucosal component and lymph node metastatic lesions were classified as P-group in 48% and 43% of cases, respectively, and as L-group in 50% and 52% of cases, respectively. (4) Lymph node metastatic lesions comprising undifferentiated carcinoma were classified as L-group in 100% of cases.
CONCLUSION: During the course of tumour progression, early differentiated adenocarcinoma at first tends to lose its phenotypic expression despite preserving its morphology, but subsequently morphological dedifferentiation occurs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16178890     DOI: 10.1111/j.1365-2559.2005.02242.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  7 in total

1.  Relationship between clinicopathological features and mucin phenotypes of advanced gastric adenocarcinoma.

Authors:  Fumiaki Toki; Atsushi Takahashi; Ryusuke Aihara; Kyoichi Ogata; Hiroyuki Ando; Tetsuro Ohno; Erito Mochiki; Hiroyuki Kuwano
Journal:  World J Gastroenterol       Date:  2010-06-14       Impact factor: 5.742

2.  Comparison of site-specific gene expression levels in primary tumors and synchronous lymph node metastases in advanced gastric cancer.

Authors:  Akira Naruke; Mizutomo Azuma; Atsuko Takeuchi; Kenji Ishido; Chikatoshi Katada; Tohru Sasaki; Katsuhiko Higuchi; Satoshi Tanabe; Makoto Saegusa; Wasaburo Koizumi
Journal:  Gastric Cancer       Date:  2014-03-21       Impact factor: 7.370

3.  Re-evaluation of phenotypic expression in undifferentiated-type early gastric adenocarcinomas using mucin core protein and CDX2.

Authors:  Satoshi Ikarashi; Ken Nishikura; Yoichi Ajioka; Yutaka Aoyagi
Journal:  Gastric Cancer       Date:  2012-07-25       Impact factor: 7.370

4.  The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer.

Authors:  Yun-Suhk Suh; Hyuk-Joon Lee; Eun-Jung Jung; Min-A Kim; Ki Taek Nam; James R Goldenring; Han-Kwang Yang; Woo Ho Kim
Journal:  Ann Surg Oncol       Date:  2011-11-03       Impact factor: 5.344

5.  The transcription factor MIST1 is a novel human gastric chief cell marker whose expression is lost in metaplasia, dysplasia, and carcinoma.

Authors:  Jochen K M Lennerz; Seok-Hyung Kim; Edward L Oates; Won Jae Huh; Jason M Doherty; Xiaolin Tian; Andrew J Bredemeyer; James R Goldenring; Gregory Y Lauwers; Young-Kee Shin; Jason C Mills
Journal:  Am J Pathol       Date:  2010-08-13       Impact factor: 4.307

Review 6.  Clinicopathologic and molecular characteristics of gastric cancer showing gastric and intestinal mucin phenotype.

Authors:  Naohide Oue; Kazuhiro Sentani; Naoya Sakamoto; Wataru Yasui
Journal:  Cancer Sci       Date:  2015-07-07       Impact factor: 6.716

7.  Gastric mucin phenotype indicates aggressive biological behaviour in early differentiated gastric adenocarcinomas following endoscopic treatment.

Authors:  Kai Song; Qi Yang; Yu Yan; Xiaoyan Yu; Kanlun Xu; Jinghong Xu
Journal:  Diagn Pathol       Date:  2021-07-13       Impact factor: 2.644

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.